Cargando…

Cyclophosphamide-Induced Cardiomyopathy: A Case Report, Review, and Recommendations for Management

Cyclophosphamide is increasingly used to treat various types of cancers and autoimmune conditions. Higher doses of this drug may produce significant cardiac toxicity, including fatal hemorrhagic myocarditis. In this review, we present a case of cyclophosphamide-induced cardiomyopathy requiring mecha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhesi, Sumandeep, Chu, Michael P., Blevins, Gregg, Paterson, Ian, Larratt, Loree, Oudit, Gavin Y., Kim, Daniel H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528786/ https://www.ncbi.nlm.nih.gov/pubmed/26425570 http://dx.doi.org/10.1177/2324709613480346

Ejemplares similares

Chloroquine‐induced cardiomyopathy: a reversible cause of heart failure
por: Yogasundaram, Haran, et al.
Publicado: (2018)

Case Series of 3 Patients Diagnosed With Atypical Hemolytic Uremic Syndrome Successfully Treated With Steroids, Plasmapheresis, and Rituximab
por: Patterson, Jeffery M., et al.
Publicado: (2017)

Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia
por: Guy, Andrew, et al.
Publicado: (2021)

Low Prevalence of Cardiomyopathy in Patients with Mitochondrial Disease and Neurological Manifestations
por: Nikhanj, Anish, et al.
Publicado: (2022)

Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications
por: Zhabyeyev, Pavel, et al.
Publicado: (2023)

Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy
por: Oudit, Gavin Y., et al.
Publicado: (2006)

Persistent myopericarditis after heterologous SARS-CoV-2 mRNA vaccination
por: Wu, Kai Yi, et al.
Publicado: (2023)

Myopéricardite persistante après une vaccination hétérologue à ARNm anti-SRAS-CoV-2
por: Wu, Kai Yi, et al.
Publicado: (2023)

Clinical utility of 12‐lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy
por: Nikhanj, Anish, et al.
Publicado: (2021)

Transcriptomic Signatures of End-Stage Human Dilated Cardiomyopathy Hearts with and without Left Ventricular Assist Device Support
por: Parikh, Mihir, et al.
Publicado: (2022)

Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy
por: Das, Subhash K., et al.
Publicado: (2018)

Females Are Protected From Iron‐Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress
por: Das, Subhash K., et al.
Publicado: (2017)

Recommendations for the Management of Cardiomyopathy Mutation Carriers: Evidence, Doubts, and Intentions
por: Couto, José F., et al.
Publicado: (2023)

Reduced native right ventricular T(1 )in Anderson-Fabry disease as compared to patients with pulmonary hypertension
por: Pagano, Joseph J, et al.
Publicado: (2014)

Reduced Right Ventricular Native Myocardial T(1) in Anderson-Fabry Disease: Comparison to Pulmonary Hypertension and Healthy Controls
por: Pagano, Joseph J., et al.
Publicado: (2016)

Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry
por: Dingli, David, et al.
Publicado: (2023)

Sarcoidosis: a prospective observational cohort from Northern Alberta
por: Vethanayagam, Dilini, et al.
Publicado: (2020)

Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-α
por: Marquez-Curtis, Leah A., et al.
Publicado: (2012)

Cyclophosphamide: Death: case report
Publicado: (2021)

Cyclophosphamide: Thrombocytopenia: case report
Publicado: (2021)

Thermochemotherapy-induced resistance to cyclophosphamide.
por: Urano, M., et al.
Publicado: (1988)

Cyclophosphamide-Induced Lung Injury
por: Pugh, Dan, et al.
Publicado: (2018)

Changes in the Left Ventricular Eicosanoid Profile in Human Dilated Cardiomyopathy
por: Sosnowski, Deanna K., et al.
Publicado: (2022)

Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry
por: Schrezenmeier, Hubert, et al.
Publicado: (2020)

Cyclophosphamide: Lack of efficacy: case report
Publicado: (2020)

Management of Chemotherapy Induced Cardiomyopathy
por: Saidi, Abdulfattah, et al.
Publicado: (2011)

Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19
por: Oudit, Gavin Y, et al.
Publicado: (2020)

Leveraging weakness into strength: how neo-patrimonial oil-producing countries survive economic crises
por: Leon, Daniel S., et al.
Publicado: (2022)

Interstitial pneumonia induced by cyclophosphamide: A case report and review of the literature
por: Qian, Panpan, et al.
Publicado: (2019)

Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy
por: Aziz-Bose, Rahela, et al.
Publicado: (2022)

Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study
por: Greil, Richard, et al.
Publicado: (2021)

Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy
por: Das, Subhash K., et al.
Publicado: (2015)

The Isopropyl Gallate Counteracts Cyclophosphamide-Induced Hemorrhagic Cystitis in Mice
por: Almeida de Oliveira, Lucas Solyano, et al.
Publicado: (2022)

Cyclophosphamide/prednisone: Various infections: case report
Publicado: (2021)

Cyclophosphamide/methylprednisolone/prednisone: No improvement: case report
Publicado: (2022)

STUDIES ON CYCLOPHOSPHAMIDE-INDUCED TOLERANCE TO SHEEP ERYTHROCYTES
por: Aisenberg, Alan C.
Publicado: (1967)

Cyclophosphamide-induced nail hyperpigmentation in a child
por: Saha, A., et al.
Publicado: (2012)

Low-dose cyclophosphamide-induced acute hepatotoxicity
por: Subramaniam, S. Ravih, et al.
Publicado: (2013)

The Role of Antioxidants in Ameliorating Cyclophosphamide-Induced Cardiotoxicity
por: Ayza, Muluken Altaye, et al.
Publicado: (2020)

It Is Not Pneumocystis jiroveci (PCP), It Is Cyclophosphamide-Induced Pneumonitis
por: Bartl, Mery, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9akov4ah1gpfi4sdg16ln7vp97